A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer.
Saved in:
| Title: | A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer. |
|---|---|
| Authors: | Tasaki Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Naiki T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.; Department of Urology, Nagoya City University West Medical Center, Nagoya, Aichi, Japan., Mimura Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Sugiyama Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Tomita M; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Morikawa T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Nagai T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Unno R; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Etani T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Hamamoto S; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Umemoto Y; Department of Urology, Nagoya City University West Medical Center, Nagoya, Aichi, Japan., Yasui T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan., Furukawa-Hibi Y; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Oct 06; Vol. 16, pp. 1681734. Date of Electronic Publication: 2025 Oct 06 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41122172 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tasaki+Y%22">Tasaki Y</searchLink>; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Naiki+T%22">Naiki T</searchLink>; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.; Department of Urology, Nagoya City University West Medical Center, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Mimura+Y%22">Mimura Y</searchLink>; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Sugiyama+Y%22">Sugiyama Y</searchLink>; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Tomita+M%22">Tomita M</searchLink>; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Morikawa+T%22">Morikawa T</searchLink>; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Nagai+T%22">Nagai T</searchLink>; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Unno+R%22">Unno R</searchLink>; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Etani+T%22">Etani T</searchLink>; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Hamamoto+S%22">Hamamoto S</searchLink>; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Umemoto+Y%22">Umemoto Y</searchLink>; Department of Urology, Nagoya City University West Medical Center, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Yasui+T%22">Yasui T</searchLink>; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Furukawa-Hibi+Y%22">Furukawa-Hibi Y</searchLink>; Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Oct 06; Vol. 16, pp. 1681734. <i>Date of Electronic Publication: </i>2025 Oct 06 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41122172 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1681734 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1681734 Titles: – TitleFull: A high eosinophil proportion increases the risk of skin-related adverse events induced by apalutamide in patients with prostate cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tasaki Y – PersonEntity: Name: NameFull: Naiki T – PersonEntity: Name: NameFull: Mimura Y – PersonEntity: Name: NameFull: Sugiyama Y – PersonEntity: Name: NameFull: Tomita M – PersonEntity: Name: NameFull: Morikawa T – PersonEntity: Name: NameFull: Nagai T – PersonEntity: Name: NameFull: Unno R – PersonEntity: Name: NameFull: Etani T – PersonEntity: Name: NameFull: Hamamoto S – PersonEntity: Name: NameFull: Umemoto Y – PersonEntity: Name: NameFull: Yasui T – PersonEntity: Name: NameFull: Furukawa-Hibi Y IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 10 Text: 2025 Oct 06 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |